Related Experiment Video
Updated: Aug 12, 2026

Enhanced Extraction of Low-Molecular Weight DNA from Wastewater for Comprehensive Assessment of Antimicrobial Resistance
Published on: July 19, 2024
Evaluating the National Action Plan (NAP) on antimicrobial resistance, and recommendations for the next 5-year NAP: a
1Policy and Diversity Officer, Applied Microbiology International, Cambridge, CB1 2LA, United Kingdom.
Insights
The UK
Area of Science:
- Microbiology and Public Health
- One Health Approach
Background:
- The UK's 2019-2024 National Action Plan (NAP) on antimicrobial resistance (AMR) is concluding.
- A new 5-year NAP is under development, necessitating an analysis of progress and future strategies.
- An addendum to the current NAP includes revised commitments for AMR containment.
Purpose of the Study:
- To analyze progress on the UK's National Action Plan (NAP) for antimicrobial resistance (AMR).
- To gather expert recommendations for the upcoming 5-year NAP.
- To identify key challenges and considerations for effective AMR policy.
Main Methods:
- Convened a roundtable discussion with UK human and animal health sector experts in November 2022.
- Facilitated discussion on progress, recommendations, and future considerations for AMR action plans.
- Analyzed expert feedback to identify barriers and priorities.
Main Results:
- A significant gap exists between the rising ambitions of the NAP and diminishing financial support.
- Challenges include translating evidence into practical, real-world implementation.
- Lack of communication and funding are primary barriers to achieving NAP commitments.
Conclusions:
- Prioritize the successful implementation of current NAP commitments before setting future goals.
- Address funding shortfalls and improve communication to overcome AMR containment barriers.
- Policymakers must consider these critical areas for effective AMR strategies.
Abstract:
The UK's current 5-year National Action Plan (NAP) on tackling antimicrobial resistance (AMR), which runs from 2019 to 2024, is coming to an end. As such, the next 5-year NAP is currently under development, and progress made towards the UK's commitments on AMR is being analysed. This analysis has involved the publication of an addendum to the current NAP, which includes some new and revised commitments. Applied Microbiology International (AMI) held a roundtable discussion in November 2022, inviting UK experts from across the human and animal sectors to discuss their thoughts on progress to date, as well as any recommendations and key considerations they thought should be taken forward. Overall, it was agreed that there is a major disparity between the increasing ambitions of the NAP, and the reducing financial support for achieving said ambitions. The gap between evidence generation and implementing recommendations into real-world settings also presents a key challenge to overcome, if the NAPs commitments are to be achieved. A lack of communication and funding appear to underpin many of the barriers that prevent the successful delivery of current NAP commitments and are therefore highlighted as key areas of concern for policymakers to consider when looking to tackle AMR. The focus should be on successfully implementing and delivering the current NAP commitments ahead of identifying future ambitions.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Microbiota Modulation by Antibiotics
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Production of Antibiotics